Psychedelic Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.6 Billion by the year 2034 at a 15.6 % CAGR during the forecast period for 2025-2034. Psychedelic medicines are also referred to as hallucinogenic. Psychedelic medicines are a group of substances, including chemicals, such as LSD, and plants used to treat multiple mental disorders, including resistant depression, opiate addiction, and pani...
Report ID: 1329 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Global Mental Wellness Market Size is valued at USD 159.0 Billion in 2024 and is predicted to reach USD 355.4 Billion by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increased smartphone adoption and mHealth therapies are driving the mental wellness market. Growing Awareness of Stress Management is driving the mental wellness market. North America domin...
Report ID: 1330 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global Biopharmaceutical Fermentation Market Size is valued at 10.5 Billion in 2024 and is predicted to reach 19.6 Billion by the year 2034 at an 6.6 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing emphasis of companies on creating innovative biological drugs is projected to drive the need for fermentation services and products, contributing to market growth. However, adhe...
Report ID: 1410 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global Rare Kidney Diseases Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 8.1 Billion by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The emergence of the rare kidney disease market is credited to the improved understanding and identification of these conditions, resulting in higher diagnosis rates. The increasing incidences an...
Report ID: 1414 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Global PARP Inhibitors Market Size is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 15.5 Billion by the year 2034 at a 15.2% CAGR during the forecast period for 2025-2034. Poly ADP-ribose polymerase or PARP inhibitor is a constituent that blocks the PARP enzyme in the cell. During cancer, DNA damage occurs. Inhibiting or blocking PARP helps the tumor cells in restoring their damaged part of DNA. Various forms of cancer ...
Report ID: 1169 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
iPSCs Manufacturing Services Market Size is valued at USD 1.3 billion in 2024 and is predicted to reach USD 4.6 billion by the year 2034 at a 14.1 % CAGR during the forecast period for 2025-2034. Induced Pluripotent Stem Cells (iPSC) are originated from skin or blood cells. iPSCs are cells that are reprogrammed from somatic cells using different transcription factors. These cells are pluripotent, have the potential for...
Report ID: 1223 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
The Patient Recruitment and Retention Services Market Size is valued at USD 4.1 Billion in 2024 and is predicted to reach USD 6.7 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034. Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the r...
Report ID: 1335 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
The Nuclear Pharmacy Market Size is valued at USD 6.27 Bn in 2024 and is predicted to reach USD 17.96 Bn by the year 2034 at a 11.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is growing because technological developments have made it possible to diagnose and treat malignant tumours with radiopharmaceuticals. Rising government financing for nuclear medic...
Report ID: 1980 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Vaccine Contract Manufacturing Market Size is valued at USD 2.3 Bn in 2024 and is predicted to reach USD 3.9 Bn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The vaccine contract manufacturing market is experiencing significant growth driven by increasing demand for vaccines globally, Asia-Pacific is anticipated to exhibit the most r...
Report ID: 2303 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
Gene Therapy Market Size is valued at USD 2.4 Bn in 2024 and is predicted to reach USD 13.6 Bn by the year 2034 at a 19.05% CAGR during the forecast period for 2025-2034 Gene therapy is a therapeutic approach that targets the fundamental genetic problem in order to treat or prevent diseases. Gene therapy offers an alternative to medications or surgery, enabling doctors to address a condition by modifying an individual's ge...
Report ID: 2215 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
Pharmaceuticals